IDEXX Laboratories, Inc.

IDXX Healthcare Diagnostics & Research

IDEXX Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 10.4% from fiscal 2024.

Revenue
+9.86%
EPS
+17.3%
Free cash flow
+17.6%
Total debt
−28.6%

Quarter to September 2026, against a year earlier

669.01 29.54 −4.23%
Market cap
$52.8B
P/E
44.8×
Fwd P/E
37.3×
Dividend yield
—
F-score
8/9
Altman Z
24.09
Beneish M
−2.50
Dividend safety
n/a

IDEXX Laboratories, Inc. (IDXX) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, IDEXX Laboratories, Inc. (IDXX) trades at a EV/EBITDA of 31.8×. Over the past ten years it has ranged from 16.9× (January 2016) to 63.2× (August 2021); the current reading is higher than 40% of that period. That is above the Diagnostics & Research industry median of 23.4× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 36.3× 32.78%
FY2024 27.4× (27.50%)
FY2023 37.7× 10.20%
FY2022 34.2× (37.51%)
FY2021 54.8× 0.31%
FY2020 54.6× 49.61%
FY2019 36.5× 26.09%
FY2018 29.0× 2.73%
FY2017 28.2× 12.52%
FY2016 25.1× 32.37%

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 24.8× (4.20%)
Jun 2026 25.9× (10.41%)
Mar 2026 28.9× (20.33%)
Dec 2025 36.3× 2.04%
43 more quarters

Against its own ten years

Low 16.9× High 63.2×
Ten-year median 33.6×
Current reading's percentile 40

EV/EBITDA against peers

Company EV/EBITDA
NTRA Natera, Inc. compare n/m
DGX Quest Diagnostics Incorporated compare 14.2×
LH Labcorp Holdings Inc. compare 15.6×
IQV IQVIA Holdings Inc. compare 16.5×
ILMN Illumina, Inc. compare 26.4×
A Agilent Technologies, Inc. compare 26.4×
MTD Mettler-Toledo International, Inc. compare 27.4×
IDXX IDEXX Laboratories, Inc. 31.8×
WAT Waters Corporation compare 51.9×
Diagnostics & Research industry median 23.4×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on IDXX